RE:RE:I have a 40 page LABS research / valuation report available Trebor, on Danny's spreadsheet I saw a column called "Estimated 2024 Net Revenue".
For Medipharm he has $40 million in revenue anticipated for next year.
So breaking it up by quarter he's probably anticipating about $8 - $10m.
From my perspective, given what we know, that seems about right.
As all of us can see - there are lots of potential avenues for sales growth, but nothing concrete at this point.